Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health ...

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

In future, a more detailed understanding of the lung microbiome in pneumonia may enable improved diagnostics, prognosis, and therapeutics.

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind” or the 'Company'), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics ...

Synaptic plasticity—the brain's ability to modify the connections between neurons to support learning—is one of the neural ...

A new study identifies a mechanism for how COVID vaccines may, in infrequent cases, drive heart inflammation, a condition ...

In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...

New industrial development initiatives are under way in Alabama and Texas. While a Norfolk Southern (NS)-served site in ...

In his proposal to NSF, Luo coined this rich-get-richer effect “annotation inequality.” One problem of annotation inequality ...

Musculoskeletal disorders and injuries are a leading cause of disability worldwide, severely affecting quality of life and creating a significant ...

StemRIM Inc. ( ($JP:4599) ) has shared an announcement. StemRIM Inc. reported its financial results for the three months ending October 31, 2025, ...

Eli Lilly and Company announced Tuesday it was investing more than $6 billion in a new manufacturing facility in Huntsville, ...